Skip to main content
Aligned Genetics, Inc. logo

Aligned Genetics, Inc. — Investor Relations & Filings

Ticker · 238120 ISIN · KR7238120000 KO Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2024-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 238120

About Aligned Genetics, Inc.

https://en.alignedgenetics.com

Aligned Genetics, Inc. is a company that develops, manufactures, and sells advanced solutions for cellular imaging, biomolecular analysis, and molecular diagnostics. It provides cutting-edge equipment, automated systems, imaging instruments, and reagents for laboratories in the life science and medical fields. The company focuses on developing molecular diagnostic solutions that deliver rapid and accurate results to support faster clinical care. Aligned Genetics aims to improve human health by creating technologies that offer deeper insights into cellular and molecular processes.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Aligned Genetics (주식회사 얼라인드제네틱스) for the fiscal year ending December 31, 2023. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. It is not an announcement of a report, but the full audit report itself, which falls under the 'Audit Report / Information' category. FY 2023
2024-03-18 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Aligned Genetics. It contains the meeting agenda, details on board elections, financial statement approval, and management reports. While it includes financial data, this is standard for a proxy statement/notice of meeting in the Korean market (often referred to as a 'Business Report' or 'Management Reference' document for the AGM). It is not a standalone 10-K or Annual Report, but rather the materials provided to shareholders to solicit votes and inform them of the upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2024-03-07 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의), which includes the date, location, agenda items (such as financial statement approval and director appointments), and board resolution details. This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of upcoming voting items, which falls under the Proxy Solicitation & Information Statement category.
2024-03-06 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides a summary of the audit opinion, key financial data (assets, liabilities, equity, revenue, profit), and auditor information. While it contains financial data, it is a standardized regulatory disclosure announcement regarding the submission of the audit report rather than the full annual report (10-K) itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2023
2024-03-06 Korean
[기재정정]기타경영사항(자율공시)(특허권 취득(애널라이트 수집장치, 이를 이용한 애널라이트 수집 방법 및 애널라이트 검사 시스템))
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (Aligned Genetics) regarding a patent acquisition. It is categorized as a 'voluntary disclosure' (자율공시) of a material business event. Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a standard regulatory announcement of a corporate event, it falls under the 'Regulatory Filings' (RNS) category.
2024-01-24 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Aligned) announcing a significant change in revenue or profit structure (30% or more). This is a standard preliminary earnings disclosure (often referred to as '잠정실적' or 'Earnings Release') required by the Korea Exchange (KRX) when financial results deviate significantly from previous periods. It provides key financial highlights (revenue, operating profit, net income) and the reasons for the change, but it is not the full annual report. Therefore, it fits the 'Earnings Release' category. FY 2023
2024-01-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.